|
Click Here for a detailed
listing of studies, formatted as a .pdf.
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
Lumpectomy and Brachytherapy as Salvage Treatment for Local Recurrences Following Breast Conservative Therapy
Investigating Radiation Therapy: The Accelerated RT Trial
Understanding Cognition: The Columbia Cognitive
Mammary
Ductoscopy and Intraductal Biopsy for Women at High Risk for Developing
Breast Cancer, for Women Presenting with Spontaneous Nipple Discharge,
and for Women Diagnosed with Breast Cancer Undergoing Surgery to the Contralateral
Breast
A Randomized, Double Blind Placebo Controlled Phase 2 Study of FOLFOX plus or minus GDC-0449 in patients with advanced gastric and gastroesophageal junction (GEJ) carcinoma
Phase III Double-Blind Placebo-Controlled Trial Of Conventional Concurrent Chemoradiation And Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation And Adjuvant Temozolomide In Patients with Newly Diagnosed Glioblastoma.
SWOG 0424- Molecular Epidemiology Case-Series Study of Non-Small Cell Lung Cancer in Smoking and Non-Smoking Women and Men
Lymphoma
An Open-Label, Randomized, Phase 2 Study to Assess the Effectiveness of
RCHOP With or Without VELCADE in Previously Untreated Patients with Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma
Prostate
Analysis of circulating tumor cells in prostate cancer. Predicting response to taxanes: A Pilot Study
Image-Guided Intensity-Modulated Radiotherapy (IG-IMRT) for Prostate Cancer
|